Pricing Log in Create free account

Aclaris Therapeutics, Inc. (ACRS) vs Obsidian Therapeutics, Inc (OBX)

Aclaris Therapeutics, Inc. and Obsidian Therapeutics, Inc are both Biotechnology companies. Aclaris Therapeutics, Inc. and Obsidian Therapeutics, Inc are of similar size ($593.0M and $559.5M). Across the 5 metrics below, Obsidian Therapeutics, Inc leads on 3 and Aclaris Therapeutics, Inc. on 2.

Valuation

Metric ACRS OBX Biotechnology median
P/E n/m — 10.60
P/S 90.59 n/m 9.40
P/B 3.48 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 74.41 n/m 9.02
Earnings yield (14.95%) — (32.88%)
Free cash flow yield (12.99%) 0.00% (23.13%)

Profitability

Metric ACRS OBX Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin (1,413.97%) — 0.00%
Net margin (1,244.09%) — 0.00%
Free cash flow margin (1,176.61%) — 0.00%
Return on equity (55.51%) — (51.96%)
Return on assets (40.66%) — (46.06%)
Return on invested capital (107.72%) 0.00% 0.00%

Growth

Metric ACRS OBX Biotechnology median
Revenue growth (TTM) (59.34%) — 6.76%
EPS growth (last fiscal year) 69.01% (11.60%) 29.88%
Revenue growth, 5-year CAGR 3.84% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ACRS OBX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.09 4.21 4.97
Net debt to EBITDA 1.20 0.77 1.01

Dividend

Metric ACRS OBX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ACRS OBX Biotechnology median
Market cap 559.49m 593.02m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack